SCHEMBL8059593

SCHEMBL8059593

O=C(/C=C/c1cccc(Cl)c1)Nc1ccc(Cl)cc1C(=O)O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.67
KMT2A Q03164 5/20 0.67
NPC1 O15118 3/20 0.67
RAB9A P51151 3/20 0.67
SMN1; SMN2 Q16637 3/20 0.67
CYP1A2 P05177 3/20 0.67
CYP3A4 P08684 2/20 0.67
CYP2C19 P33261 2/20 0.67
EGFR P00533 2/20 0.64
TRPA1 O75762 1/20 0.62
LMNA P02545 2/20 0.59
MMP1 P03956 5/20 0.58
MMP2 P08253 5/20 0.58
MMP9 P14780 5/20 0.58
MAOB P27338 3/20 0.58
MAOA P21397 2/20 0.58
CYP2C9 P11712 2/20 0.57
CYP2D6 P10635 1/20 0.57
KDM4E B2RXH2 2/20 0.54
HSD17B10 Q99714 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8059594 1.00 MEN1 (0.67) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL8060457 0.92 EGFR (0.75) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL8060454 0.92 EGFR (0.75) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL8064168 0.90 GAA (0.59) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL8048912 0.90 EGFR (0.58) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL8064046 0.90 TRPM2 (0.61) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL417073 0.90 EGFR (0.62) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL417074 0.90 EGFR (0.62) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL8064171 0.90 GAA (0.59) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL8048908 0.90 EGFR (0.58) MEN1KMT2ANPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6127392-A A MUSCLE RELAXANT FOR TREATMENT OF DISORDERS ASSOCIATED WITH SMOOTH MUSCLE CONTRACTION VIA POTASSIUM CHANNEL AND CHLORIDE CHANNEL MODULATION; INOTROPIC AGENT AMERICAN HOME PRODUCTS CORPORATION (US) 2000-10-03 US disclosed
US-6046239-A USED IN THE TREATMENT OF DISORDERS ASSOCIATED WITH SMOOTH MUSCLE CONTRACTION, VIA POTASSIUM CHANNEL AND CHLORIDE CHANNEL MODULATION SUCH AS URINARY INCONTINENCE, ASTHMA, ANGINA, PREMATURE LABOR, CONGESTIVE HEART FAILURE AMERICAN HOME PRODUCTS CORPORATION (US) 2000-04-04 US disclosed